| A Message from The Oxford Club, LLC Dear Reader,
I am often asked what my favorite dividend stock is.
So I want to share the one single stock that's by far my favorite right now.
Unlike many dividend-paying companies... which rely on boring income through utilities, rent or oil...
This company owns the bestselling drug in the world, which brought in $19.9 billion in revenue last year.
And it has a pipeline of other blockbuster drugs, which are expected to generate $35 billion in sales.
It doesn't take a genius to know that healthcare is at the forefront of everyone's mind right now, including the folks on Wall Street.
Last year, this company's stellar drug sales allowed it to pay shareholders $5.6 billion in dividends.
That's cash you can claim a piece of.
And today, I want to give you the name, the ticker symbol and my full analysis completely free - no strings attached.
Click here to get it.
Sincerely,
Marc Lichtenfeld
Chief Income Strategist, The Oxford Club
P.S. When I say FREE, I mean it. There is no catch. You get my entire Ultimate Dividend Package... including my No. 1 dividend stock... free of charge. Here's how.
This ad is sent on behalf of The Oxford Club. 105 W Monument St, Baltimore, Maryland 21201. If you would like to optout from receiving offers from The Oxford Club please click here.
-- | | This message is a paid advertisement sent on behalf of The Oxford Club, LLC, a third-party advertiser of Trading with Manny.
From time to time your free Trading With Manny newsletter subscription is supplemented by paid sponsorships, like the one above. Please read all disclaimers. Rest assured that your information was not shared with this sponsor. Please note that Trading With Manny has not independently reviewed the validity of the claims or statements contained within this sponsorship, and we are not responsible for any errors or omissions.
Never invest in a security or idea featured on our site or in our emails unless you can afford to lose your entire investment. We are not registered investment advisors or brokers/dealers and we do not purport to be. We make no representations, warranties or guarantees as to the accuracy or completeness of the content featured on our site or in our emails. Furthermore, the article authors and contributors featured on this site may own securities mentioned in their articles and not disclose this information. Trading With Manny does not endorse any investing or trading products or newsletters advertised in this email or on our web site. Please be sure to read our
| | Go here to get more information from
| | |
|
